为您找到"
688185
"相关结果约100,000,000个
688185 | Complete CanSino Biologics Inc. A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get the latest Cansino Biologics Inc (688185) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Find the latest CanSino Biologics Inc. (688185.SS) stock quote, history, news and other vital information to help you with your stock trading and investing.
About CanSino Biologics. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides.
Get CanSino Biologics Inc (688185.SS) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
688185 is trading within a range we consider fairly valued. Price ¥64.21. Feb 21, 2025. Fair Value ¥75.96. Feb 15, 2025. Uncertainty High. 1-Star Price ¥97.23. 5-Star Price ...
Stock analysis for CanSino Biologics Inc (688185:Shanghai) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
CanSino Biologics Inc. is a biopharmaceutical company that develops and commercializes innovative vaccine products for human use worldwide. It has two approved vaccines for Ebola and COVID-19, and 16 vaccine candidates in the pipeline, with a GMP manufacturing capacity of 70-80 million doses.
On Friday, CanSino Biologics Inc (688185:SHH) closed at 55.28, 48.92% above the 52 week low of 37.12 set on Aug 23, 2024.
提供康希诺(688185)股票的行情走势、五档盘口、逐笔交易等实时行情数据，及康希诺(688185)的新闻资讯、公司公告、研究报告、行业研报、f10资料、行业资讯、资金流分析、阶段涨幅、所属板块、财务指标、机构观点、行业排名、估值水平、股吧互动等与康希诺(688185)有关的信息和服务。